Brain immune cells, neurodegeneration differ in males, females

Researchers from Weill Cornell Medicine report immune cell activity in the brain differs between males and females in ways that may explain why some neurodegenerative diseases affect the sexes differently.

Pollack keynote kicks off Mentoring Month at Weill Cornell

Cornell President Martha E. Pollack recounted her experiences as both a mentee and a mentor as the keynote speaker Jan. 15 for Weill Cornell Medicine’s inaugural Mentoring Month.

Collaboration reveals potential new therapy for osteoarthritis

Recent multidisciplinary research at Cornell, led by Dr. Michelle Delco from the College of Veterinary Medicine, reveals that the application of a proprietary peptide may protect cartilage from osteoarthritis.

Weill Cornell radiologist to lead enhanced MRI research facility

Dr. Sumit Narayan Niogi, assistant professor of radiology and clinical associate in radiology at Weill Cornell Medicine, has been named director of the Cornell Magnetic Resonance Imaging Facility.

Research tops list of 2019’s most read stories

Of the approximately 1,500 stories posted by the Cornell Chronicle, research stories about air pollution, engineering and genetics were the four most-read stories of the past 12 months.

Weill Cornell center aims to help cognitively impaired seniors

Weill Cornell Medicine has been awarded a five-year, $4.6 million grant to create a center aimed at developing technology to help older adults who have cognitive impairments.

Multiplexed C dots track cancer cells to improve patient care

Researchers are using glowing nanoparticles called C dots to detect multiple cancer markers during surgery in a way that is both precise and safe.

Immunology workshop to demystify cutting-edge tech

An Immunoprofiling Workshop – sponsored by the Cornell Center for Immunology, Dec. 13 in Stocking Hall – will feature technology experts who will provide case studies and best practices on various core technologies.

Protein finding could inform new type 2 diabetes treatment

Researchers at Weill Cornell Medicine and NewYork-Presbyterian have discovered a function of the protein adipsin that could help inform new treatments for type 2 diabetes.